Clinical Trial Update: Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update noting completion of a Phase 1/Phase 2 study of PHY906 plus capecitabine in advanced unresectable hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• PHY906

Snippet

Sponsor: PhytoCeutica | Conditions: Hepatocellular Carcinoma, Liver Cancer | Phase 1, Phase 2 | Status: COMPLETED